BFM
BSTC

Boothbay Fund Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Boothbay Fund Management’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,204
Closed -$238K – 1009
2016
Q3 		$238K Buy
+5,204
New +$209K 0.05% 479

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Boothbay Fund Management's BSTC Position: Q4 2016 in Review

Boothbay Fund Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2016, closing a stake of 5,204 shares — an estimated $238K sold.

Boothbay Fund Management first reported a position in BSTC in Q3 2016 and held it in 1 quarter. The position peaked at $238K in Q3 2016. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

  • Boothbay Fund Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2016 after selling out during the quarter.
  • Boothbay Fund Management sold 5,204 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $238K.
  • Boothbay Fund Management first reported a position in BioSpecifics Technologies Corp. in Q3 2016 and held it in 1 quarter.
  • Boothbay Fund Management's BioSpecifics Technologies Corp. position peaked at $238K in Q3 2016.
  • 96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on Boothbay Fund Management's 13F filing for Q4 2016, filed 15 Feb 2017.